Global Acoustic Medicine and Ultrasound Therapy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Acoustic Medicine and Ultrasound Therapy Market Size

• The global acoustic medicine and ultrasound therapy market size was valued at USD 1.91 billion in 2024 and is expected to reach USD 3.02 billion by 2032, at a CAGR of 5.87% during the forecast period
• The market growth is primarily driven by the increasing prevalence of musculoskeletal disorders, chronic pain, and sports-related injuries, coupled with the rising preference for non-invasive and drug-free treatment options across healthcare settings
• In addition, growing clinical adoption of focused ultrasound technologies for targeted drug delivery, regenerative medicine, and soft tissue repair is reshaping therapeutic paradigms. These synergistic trends are advancing the demand for acoustic and ultrasound-based therapeutic devices, thus fueling consistent market expansion

Acoustic Medicine and Ultrasound Therapy Market Analysis

• Acoustic medicine and ultrasound therapy devices, which utilize sound waves to promote healing, reduce pain, and stimulate tissue regeneration, are becoming increasingly integral to modern therapeutic practices across sports medicine, physiotherapy, and chronic pain management, owing to their non-invasive nature, precision, and minimal side effects
• The growing demand for ultrasound therapy is primarily driven by the rising incidence of musculoskeletal injuries, expanding geriatric population, and increasing preference for drug-free, outpatient-based recovery solutions
• North America dominated the acoustic medicine and ultrasound therapy market with the largest revenue share of 39.2% in 2024, bolstered by advanced healthcare infrastructure, favorable reimbursement policies, and widespread adoption in orthopedic and rehabilitation centers, especially in the U.S., where sports injury rehabilitation and chronic pain treatment are major applications
• Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by increasing healthcare investments, growing awareness of non-invasive therapies, and rising prevalence of age-related degenerative disorders
• The therapeutic ultrasound segment dominated the acoustic medicine and ultrasound therapy market with a share of 46.1% in 2024, owing to its proven efficacy in soft tissue repair, pain relief, and enhanced circulation, as well as its broad applicability across various clinical specialties

Report Scope and Acoustic Medicine and Ultrasound Therapy Market Segmentation

Acoustic Medicine and Ultrasound Therapy Market Trends

“Rising Use of Focused Ultrasound and AI-Enhanced Therapeutics”

• A significant and emerging trend in the global acoustic medicine and ultrasound therapy market is the increasing integration of artificial intelligence (AI) and the rapid development of focused ultrasound (FUS) technologies. These advancements are greatly improving precision, treatment outcomes, and patient safety across various therapeutic applications, including musculoskeletal pain, oncology, and neurology
  • For instance, companies such as Insightec have developed FUS systems that use real-time MRI guidance and AI algorithms to non-invasively treat conditions such as essential tremor and uterine fibroids with pinpoint accuracy. These innovations enhance treatment efficiency and reduce recovery time
• AI-enhanced ultrasound therapy platforms are also enabling better diagnostics and personalized treatment plans by analyzing tissue response patterns and adjusting therapy parameters accordingly. This capability is particularly beneficial in chronic pain management and rehabilitation therapy
• The ability to deliver non-invasive, image-guided therapy through intelligent systems is expanding the clinical use cases for ultrasound beyond traditional physical therapy, into fields such as neuromodulation and regenerative medicine
• In addition, the miniaturization of devices and development of portable ultrasound units are enhancing accessibility in outpatient and homecare settings, aligning with the broader trend of decentralized healthcare delivery
• This shift toward AI-powered, high-precision, and mobile ultrasound therapy solutions is redefining therapeutic standards and significantly broadening the scope of acoustic medicine applications across global healthcare markets

Acoustic Medicine and Ultrasound Therapy Market Dynamics

Driver

“Growing Demand for Non-Invasive and Drug-Free Therapeutic Modalities”

• The rising demand for non-invasive, drug-free treatment options is a major driver accelerating the growth of the acoustic medicine and ultrasound therapy market. Increasing incidences of musculoskeletal conditions, sports injuries, and chronic pain—especially among aging populations—are fueling the need for safer, repeatable, and side-effect-free therapies
  • For instance, in January 2024, ZetrOZ Systems launched a next-generation wearable sustained acoustic medicine (sam) device aimed at delivering daily ultrasound therapy for soft tissue injuries. Such product innovations are driving broader clinical adoption and patient compliance
• Ultrasound therapy offers significant advantages, including pain reduction, accelerated healing, and minimal downtime, which make it highly attractive in orthopedic, physiotherapy, and rehabilitation settings
• In addition, increasing awareness and endorsement by healthcare professionals for its efficacy and safety profile are further promoting its use. The expansion of outpatient rehabilitation clinics and the rising availability of portable ultrasound devices are also playing key roles in driving market penetration
• Government support for non-opioid pain management strategies in regions such as North America and Europe is enhancing demand for these technologies in public healthcare systems and sports medicine programs

Restraint/Challenge

“Limited Reimbursement Policies and Technical Skill Barriers”

• One of the key challenges limiting the widespread adoption of acoustic medicine and ultrasound therapy is the inconsistent reimbursement coverage across different regions and medical use cases. While clinical benefits are recognized, lack of formal reimbursement codes in many healthcare systems restricts access and usage, particularly in developing economies
• Moreover, successful deployment of therapeutic ultrasound requires skilled operators for precise application, which may limit adoption in facilities lacking trained personnel or access to specialized training programs
  • For instance, advanced systems such as MR-guided focused ultrasound require both technical expertise and specialized infrastructure, restricting their availability to high-end clinics or tertiary care centers
• In addition, despite increasing portability, some therapeutic ultrasound equipment still requires professional handling and careful calibration, which could deter its use in homecare or unsupervised settings
• Overcoming these limitations through broader insurance support, clinician training programs, and user-friendly device designs will be essential to unlocking the full potential of this market

Acoustic Medicine and Ultrasound Therapy Market Scope

The market is segmented on the basis of technology, modality, portability, application, and end user.

• By Technology

On the basis of technology, the acoustic medicine and ultrasound therapy market is segmented into diagnostic and therapeutic. The therapeutic segment dominated the market with the largest market revenue share of 46.1% in 2024, owing to the widespread use of ultrasound for pain relief, tissue healing, and drug delivery in chronic and acute care settings. Its non-invasive nature and increasing applications in musculoskeletal and rehabilitation therapies make it highly desirable among clinicians.

The diagnostic segment is anticipated to grow at the fastest CAGR from 2025 to 2032, driven by technological advancements such as AI-enhanced imaging and real-time diagnostics. The rising demand for early and accurate disease detection in areas such as cardiology and obstetrics is fueling increased adoption of diagnostic ultrasound solutions in both hospital and outpatient settings.

• By Modality

On the basis of modality, the acoustic medicine and ultrasound therapy market is segmented into bench-top, hand-held, and others. The bench-top segment held the highest market share in 2024 due to its use in hospitals and research institutions where advanced functionality, accuracy, and higher imaging power are required. Bench-top devices are preferred for continuous therapy and high-frequency applications in rehabilitation centers.

The hand-held segment is expected to witness the fastest growth rate from 2025 to 2032, attributed to the growing demand for portable, point-of-care solutions and the expansion of home-based care. These devices are gaining popularity due to their compact form, affordability, and usability in remote or underserved areas, especially for physical therapy and sports injury recovery.

• By Portability

On the basis of portability, the acoustic medicine and ultrasound therapy market is segmented into trolley/cart-based and compact/handheld systems. The trolley/cart-based segment dominated the market in 2024 due to its integration in hospitals and specialized physiotherapy units where multiple treatment modules and power capacity are needed.

The compact/handheld segment is projected to grow at the fastest CAGR over the forecast period, fueled by increasing demand for portable ultrasound therapy systems in home healthcare, sports clinics, and ambulatory surgical centers. The ease of use, affordability, and growing consumer interest in wearable ultrasound for chronic pain and injury management are key growth contributors.

• By Application

On the basis of application, the acoustic medicine and ultrasound therapy market is segmented into emergency medicine, cardiology, obstetrics and gynecology, oncology surgery, urology, vascular surgery, musculoskeletal, osteoarthritis, space adaptation back pain, sports injuries, trapezius muscle spasm, and others. The musculoskeletal segment held the largest revenue share in 2024, driven by increasing demand for ultrasound therapy in treating soft tissue injuries, tendinopathies, and joint disorders.

The sports injuries segment is expected to register the fastest growth during forecast period, supported by rising participation in sports, greater awareness about non-invasive recovery options, and the availability of targeted ultrasound therapy for injury rehabilitation.

• By End User

On the basis of end user, the acoustic medicine and ultrasound therapy market is segmented into hospitals, private clinics, medical research institutes, physiotherapy centers, chiropractic clinics, healthcare settings, public health agencies, and others. The hospitals segment led the market in 2024 due to widespread use of ultrasound therapy in comprehensive pain management programs and orthopedic departments.

The physiotherapy centers segment is projected to grow at the highest CAGR, propelled by the increasing referral of patients for rehabilitation therapy using portable and specialized ultrasound equipment, and the rising number of outpatient centers offering advanced therapeutic services.

Acoustic Medicine and Ultrasound Therapy Market Regional Analysis

• North America dominated the acoustic medicine and ultrasound therapy market with the largest revenue share of 39.2% in 2024, bolstered by advanced healthcare infrastructure, favorable reimbursement policies, and widespread adoption in orthopedic and rehabilitation centers, especially in the United States, where sports injury rehabilitation and chronic pain treatment are major applications
• Patients and healthcare providers in the region prioritize drug-free pain management, fast recovery, and precision-based therapies, all of which are effectively delivered through therapeutic ultrasound solutions
• This widespread clinical adoption is further supported by favorable reimbursement policies, strong presence of key medical device manufacturers, and the growing trend toward outpatient care and home-based therapeutic solutions, establishing ultrasound therapy as a preferred modality across diverse medical disciplines

U.S. Acoustic Medicine and Ultrasound Therapy Market Insight

The U.S. acoustic medicine and ultrasound therapy market captured the largest revenue share of 79% in 2024 within North America, driven by the widespread use of non-invasive treatments in sports medicine, physical therapy, and chronic pain management. Rising healthcare expenditure, robust insurance coverage for outpatient therapy, and strong clinical evidence supporting therapeutic ultrasound are accelerating market adoption. In addition, the presence of leading medical device innovators and increased demand for home-based ultrasound therapy devices further support market growth.

Europe Acoustic Medicine and Ultrasound Therapy Market Insight

The Europe acoustic medicine and ultrasound therapy market is projected to expand at a substantial CAGR throughout the forecast period, fueled by growing demand for drug-free pain relief and increasing musculoskeletal disorders among the aging population. Rising emphasis on patient safety and rehabilitation efficiency is encouraging the adoption of therapeutic ultrasound in both public and private healthcare sectors. Countries across the region are investing in physiotherapy infrastructure and integrating portable ultrasound units into primary care and specialty clinics.

U.K. Acoustic Medicine and Ultrasound Therapy Market Insight

The U.K. acoustic medicine and ultrasound therapy market is anticipated to grow at a noteworthy CAGR during the forecast period, supported by rising incidences of arthritis and sports injuries, along with expanding access to physiotherapy services. Government support for non-invasive, opioid-free therapies and an increasing elderly population seeking joint and soft tissue treatments are boosting the market. Demand is further driven by the availability of advanced portable ultrasound devices suited for clinical and home use.

Germany Acoustic Medicine and Ultrasound Therapy Market Insight

The Germany acoustic medicine and ultrasound therapy market is expected to expand at a considerable CAGR during the forecast period, supported by the country's advanced healthcare system and a strong focus on innovation and preventive care. Germany’s emphasis on rehabilitation, particularly post-operative and orthopedic, is encouraging the clinical use of ultrasound therapy. Technological advancements, coupled with high adoption of physiotherapy equipment in both public and private clinics, are fueling the growth of this market.

Asia-Pacific Acoustic Medicine and Ultrasound Therapy Market Insight

The Asia-Pacific acoustic medicine and ultrasound therapy market is poised to grow at the fastest CAGR of 25.2% during the forecast period of 2025 to 2032, driven by increasing healthcare awareness, rapid urbanization, and technological improvements in countries such as China, Japan, and India. Rising healthcare investments and expansion of physiotherapy centers across the region are stimulating adoption. In addition, the manufacturing strength of APAC in medical electronics is improving the affordability and accessibility of therapeutic ultrasound systems.

Japan Acoustic Medicine and Ultrasound Therapy Market Insight

The Japan acoustic medicine and ultrasound therapy market is gaining traction due to its rapidly aging population, advanced medical infrastructure, and widespread use of physiotherapy in both hospital and homecare settings. Japan’s strong focus on minimally invasive care, combined with its leadership in medical technology, is fostering integration of ultrasound therapy in rehabilitation and orthopedic services. Increased use of wearable and AI-integrated ultrasound devices is also supporting sustained market growth.

India Acoustic Medicine and Ultrasound Therapy Market Insight

The India acoustic medicine and ultrasound therapy market accounted for the largest market revenue share in Asia-Pacific in 2024, driven by a growing middle class, increasing incidence of sports and workplace injuries, and government investments in healthcare infrastructure. Demand for non-invasive, low-cost treatment options is high, and portable ultrasound therapy devices are becoming increasingly common in physiotherapy clinics and homecare setups. Local manufacturing and the expansion of tele-rehabilitation services further contribute to the market’s rapid growth.

Acoustic Medicine and Ultrasound Therapy Market Share

The acoustic medicine and ultrasound therapy industry is primarily led by well-established companies, including:

• Mettler Electronics Corp. (U.S.)
• BTL (U.K.)
• ZetrOZ Systems (U.S.)
• Dynatronics Corporation (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Siemens AG (Germany)
• General Electric Company (U.S.)
• Canon Inc. (Japan)
• SAMSUNG (South Korea)
• Carestream Health (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Hitachi, Ltd. (Japan)
• Hologic, Inc. (U.S.)

What are the Recent Developments in Global Acoustic Medicine and Ultrasound Therapy Market?

• In March 2024, ZetrOZ Systems, a leader in sustained acoustic medicine, announced the launch of its next-generation sam wearable ultrasound device, designed for daily home use in treating soft tissue injuries. This innovation enables long-duration therapy with clinical-grade ultrasound, promoting faster healing while reducing the need for pain medications. The launch reflects ZetrOZ's commitment to expanding access to non-invasive, drug-free pain management solutions for athletes, workers, and patients with chronic conditions
• In February 2024, Insightec Ltd., a pioneer in MR-guided focused ultrasound (MRgFUS) technology, received expanded FDA approval for its Exablate Neuro system for the treatment of Parkinson’s disease. This non-invasive therapeutic solution uses ultrasound waves guided by MRI to target deep brain tissues without incisions, offering an alternative to surgery. The development strengthens Insightec’s leadership in neurological applications of acoustic medicine and highlights growing clinical interest in ultrasound-based neuromodulation
• In January 2024, Theraclion SA, a France-based innovator in ultrasound therapy, partnered with the University Hospital of Lyon to advance research on its Echopulse platform for non-invasive treatment of varicose veins. The collaboration aims to validate the clinical efficacy of ultrasound-based sclerotherapy and expand its use in vascular applications. This initiative highlights the growing interest in using high-intensity focused ultrasound (HIFU) for outpatient vascular procedures
• In December 2023, ulrich medical USA, a subsidiary of the German medical device manufacturer, launched an advanced ultrasound pain therapy system designed for integration into multidisciplinary rehabilitation centers across North America. The device features customizable frequency settings and AI-guided feedback mechanisms to ensure safe and effective pain relief. This reflects a broader trend of combining precision technology with therapeutic ultrasound for better patient outcomes
• In October 2023, Guided Therapy Systems (U.S.) unveiled its new Visage therapeutic ultrasound device designed for aesthetic and musculoskeletal treatments. The system leverages focused ultrasound energy to stimulate collagen production and alleviate deep tissue discomfort. This expansion into the wellness and aesthetic segment demonstrates the versatility of ultrasound therapy beyond traditional rehabilitation, supporting the modality’s increasing relevance in consumer-oriented health applications

SKU-61464